0001209191-17-053214.txt : 20170918
0001209191-17-053214.hdr.sgml : 20170918
20170918181548
ACCESSION NUMBER: 0001209191-17-053214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170918
FILED AS OF DATE: 20170918
DATE AS OF CHANGE: 20170918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thackray Helen M.
CENTRAL INDEX KEY: 0001589725
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36177
FILM NUMBER: 171090678
MAIL ADDRESS:
STREET 1: C/O GLYCOMIMETICS, INC.
STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLYCOMIMETICS INC
CENTRAL INDEX KEY: 0001253689
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9708 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-243-1201
MAIL ADDRESS:
STREET 1: 9708 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-18
0
0001253689
GLYCOMIMETICS INC
GLYC
0001589725
Thackray Helen M.
C/O GLYCOMIMETICS, INC.
9708 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
SVP Clinical Development, CMO
Common Stock
2017-09-18
4
S
0
2000
13.00
D
150615
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on June 19, 2017.
/s/ Brian F. Leaf, attorney-in-fact
2017-09-18